Abstract
Transthyretin-related hereditary (TTR) amyloidoses represent a clinically heterogeneous group of diseases associated with various point mutations of the TTR gene. We propose a molecular strategy for the diagnosis of this group of disorders.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amyloidosis / diagnosis*
-
Amyloidosis / genetics*
-
Base Sequence
-
Cloning, Molecular
-
Humans
-
Molecular Sequence Data
-
Mutation
-
Oligonucleotide Probes / genetics
-
Polymerase Chain Reaction
-
Polymorphism, Restriction Fragment Length
-
Prealbumin / genetics*
Substances
-
Oligonucleotide Probes
-
Prealbumin